Clinical observation of warfarin combined with low molecular weight heparin in treatment of postpartum venous thromboembolism
Yang JING,Meng DING,Yan-ping XIAO,Xiang-hua CHEN,Qing-yun ZHANG,Jiu-yuan FU
DOI: https://doi.org/10.7501/j.issn.1674-5515.2018.03.043
2018-01-01
Abstract:Objective To investigate the clinical effect of Warfarin Sodium Tablets combined with Low Molecular Weight Heparin Sodium Injection in treatment of postpartum venous thromboembolism. Methods Patients (67 cases) with postpartum venous thromboembolism in the Affiliated Hospital of Chengde Medical University from July 2010 to July 2015 were randomly divided into the control group (34 cases) and the treatment group (33 cases). Patients in the control group were sc administered with Low Molecular Weight Heparin Sodium Injection at postpartum 12 h, 100 IU/kg, twice daily. Patients in the treatment group were po administered with Warfarin Sodium Tablets on the basis of the control group, first dose 2.5 mg, once daily, adjusting the amount of warfarin according to the results, when the international normalized ratio of prothrombin time was 2 to 3, the Low Molecular Weight Heparin Sodium Injection was discontinued.. Patients in two groups were treated for 3 months. After treatment, the clinical efficacies were evaluated, and vascular patency and adverse events in two groups were compared. Results After treatment, the clinical efficacies in the control and treatment groups were 73.53％ and 90.91％, respectively, and there was difference between two groups (P < 0.05). After treatment, the vascular patency rates in the control and treatment groups were 73.53％ and 84.85％, respectively, and there was difference between two groups (P < 0.05). After treatment, the incidence rates of post thrombosis syndrome in the control and treatment groups were 35.29％ and 12.12％, respectively, and there was difference between two groups (P < 0.05). Conclusion Warfarin Sodium Tablets combined with Low Molecular Weight Heparin Sodium Injection has clinical curative effect in treatment of postpartum venous thromboembolism, can increase vascular patency, with good safety, which has a certain clinical application value.